Overall, MT5-MMP appears to be a multifaceted modulator at the crossroads of neuroinflammation, APP metabolism, and synaptic function, further enhancing interest in this proteinase and the possible therapeutic implications of its modulation in AD. This evidence concerns the gene APP and Alzheimer disease.